Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | LVTX |
---|---|---|
09:48 ET | 11191 | 1.6407 |
09:50 ET | 4613 | 1.63 |
09:56 ET | 1427 | 1.62 |
10:15 ET | 7696 | 1.6799 |
10:35 ET | 5999 | 1.67 |
10:37 ET | 6000 | 1.626 |
11:58 ET | 1000 | 1.68 |
12:41 ET | 750 | 1.68 |
01:03 ET | 4959 | 1.64 |
01:10 ET | 127 | 1.6208 |
01:44 ET | 200 | 1.62 |
01:55 ET | 1441 | 1.62 |
03:07 ET | 800 | 1.62 |
03:57 ET | 2500 | 1.68 |
03:59 ET | 267 | 1.69 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
LAVA Therapeutics NV | 44.4M | -1.9x | --- |
Kezar Life Sciences Inc | 40.3M | -0.4x | --- |
Atara Biotherapeutics Inc | 42.8M | -0.2x | --- |
DURECT Corp | 38.5M | -2.3x | --- |
Kronos Bio Inc | 60.3M | -0.6x | --- |
BioLine RX Ltd | 52.8M | -0.9x | --- |
LAVA Therapeutics NV, formerly known as Lava Therapeutics BV, is a provider of biotechnology research and development services based in the Netherlands. The Company focuses of developing next generation Vdelta T cell engaging bispecific antibodies to fight cancer.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $44.4M |
---|---|
Revenue (TTM) | $7.4M |
Shares Outstanding | 26.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.51 |
EPS | $-0.90 |
Book Value | $1.95 |
P/E Ratio | -1.9x |
Price/Sales (TTM) | 6.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -371.48% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.